Efficacy and safety of crizotinib in patients with anaplastic lymphoma kinase-positive advanced-stage non-small-cell lung cancer

Cancer Management and Research ◽

10.2147/cmar.s173084 ◽

2018 ◽

Vol Volume 10 ◽

pp. 6555-6561 ◽

Author(s):

Ahmed Mohieldin ◽

Ayman Rasmy ◽

Mohamed Ashour ◽

Muath Al-Nassar ◽

Rola H Ali ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Advanced Stage ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

Efficacy and safety of ceritinib in anaplastic lymphoma kinase‐rearranged non‐small cell lung cancer: A systematic review and meta‐analysis

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13157 ◽

2020 ◽

Vol 45 (4) ◽

pp. 743-754 ◽

Author(s):

Wei Tian ◽

Ping Zhang ◽

Yuan Yuan ◽

Xiao‐Hui Deng ◽

Rui Yue ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Meta Analysis ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

Editorial on the article entitled “brigatinib efficacy and safety in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer in a phase I/II trial”

Journal of Thoracic Disease ◽

10.21037/jtd.2016.10.57 ◽

2016 ◽

Vol 8 (10) ◽

pp. E1287-E1292 ◽

Author(s):

Ivana Sullivan ◽

David Planchard

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Download Full-text

Efficacy and Safety of Ceritinib in Patients (Pts) with Advanced Anaplastic Lymphoma Kinase (Alk)-Rearranged (Alk+) Non-Small Cell Lung Cancer (Nsclc): an Update of Ascend-1

Annals of Oncology ◽

10.1093/annonc/mdu349.74 ◽

2014 ◽

Vol 25 ◽

pp. iv456 ◽

Author(s):

E. Felip ◽

D. Kim ◽

R. Mehra ◽

D.S.W. Tan ◽

L.Q. Chow ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

The efficacy and safety of crizotinib in the treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer: a meta-analysis of clinical trials

10.1186/1471-2407-14-683 ◽

2014 ◽

Vol 14 (1) ◽

Author(s):

Haili Qian ◽

Feng Gao ◽

Haijuan Wang ◽

Fei Ma

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Meta Analysis ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

Efficacy and Safety of Ceritinib in Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Rearranged (ALK+) Non-Small Cell Lung Cancer (NSCLC): An Update of ASCEND-1

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2014.08.208 ◽

2014 ◽

Vol 90 (5) ◽

pp. S33-S34 ◽

Author(s):

D. Kim ◽

R. Mehra ◽

D.S.W. Tan ◽

E. Felip ◽

L.Q.M. Chow ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

1330: Brigatinib efficacy and safety in patients (Pts) with anaplastic lymphoma kinase (ALK)-positive (ALK+) non-small cell lung cancer (NSCLC) in a phase 1/2 trial

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(16)30245-3 ◽

2016 ◽

Vol 11 (4) ◽

pp. S114 ◽

Author(s):

R. Rosell ◽

S.N. Gettinger ◽

L.A. Bazhenova ◽

C.J. Langer ◽

R. Salgia ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Phase 1 ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Download Full-text

5P Targeted degradation of anaplastic lymphoma kinase by target degraducer in non-small cell lung cancer

Annals of Oncology ◽

10.1016/s0923-7534(21)00167-8 ◽

2016 ◽

Vol 27 ◽

pp. ix2

Author(s):

J.Y. Hwang ◽

C.-H. Park ◽

D.H. Lee ◽

C.H. Kang ◽

C.O. Lee ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

Visual Effects in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Crizotinib

Annals of Oncology ◽

10.1016/s0923-7534(20)32041-x ◽

2012 ◽

Vol 23 ◽

pp. xi44

Author(s):

P.-C. Yang ◽

R. Salgia ◽

B. Solomon ◽

A.T. Shaw ◽

D.R. Camidge ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Visual Effects ◽

Anaplastic Lymphoma ◽

Alk Positive ◽

Download Full-text

Cost-Effectiveness Analysis Of Ceritinib And Alectinib Versus Crizotinib In The Treatment Of Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer

Cancer Management and Research ◽

10.2147/cmar.s223441 ◽

2019 ◽

Vol Volume 11 ◽

pp. 9195-9202 ◽

Author(s):

Maobai Liu ◽

Longfeng Zhang ◽

Qishu Huang ◽

Na Li ◽

Bin Zheng ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Cost Effectiveness Analysis ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Effectiveness Analysis

Download Full-text

Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancer

Cancer Science ◽

10.1111/j.1349-7006.2011.01970.x ◽

2011 ◽

Vol 102 (8) ◽

pp. 1602-1604 ◽

Author(s):

Takashi Kijima ◽

Kengo Takeuchi ◽

Satoshi Tetsumoto ◽

Kazuki Shimada ◽

Ryo Takahashi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Download Full-text